Skip to main content
Erschienen in: Acta Diabetologica 5/2015

01.10.2015 | Original Article

Incidence and risk factors for severe and symptomatic hypoglycemia in type 1 diabetes. Results of the HYPOS-1 study

verfasst von: Carlo B. Giorda, Alessandro Ozzello, Sandro Gentile, Alberto Aglialoro, Anna Chiambretti, Fabio Baccetti, Francesco M. Gentile, Giuseppe Lucisano, Antonio Nicolucci, Maria Chiara Rossi, HYPOS-1 Study Group of AMD

Erschienen in: Acta Diabetologica | Ausgabe 5/2015

Einloggen, um Zugang zu erhalten

Abstract

Objective

Hypoglycemia is common in type 1 diabetes mellitus (T1DM). We aimed to update the incidence of severe and symptomatic hypoglycemia and investigate several correlated factors.

Methods

In this multicenter, observational retrospective study, the data of 206 T1DM patients from a sample of 2,229 consecutive patients seen at 18 diabetes clinics were analyzed. Sociodemographic and clinical characteristics, severe hypoglycemia in the past 12 months, and symptomatic hypoglycemia in the past 4 weeks were recorded with a self-report questionnaire and a clinical form during a routine visit. Poisson multivariate models were applied.

Results

A minority of patients accounted for the majority of both severe and symptomatic episodes. The incidence rate (IR) of severe hypoglycemia was 0.49 (0.40–0.60) events/person-years. The incidence rate ratio (IRR) was higher in patients with previous severe hypoglycemia (3.71; 2.28–6.04), neuropathy (4.16; 2.14–8.05), long duration (>20 years, 2.96; 1.60–5.45), and on polypharmacy (1.24; 1.13–1.36), but it was lower when a complication was present. The IR of symptomatic hypoglycemia was 53.3 events/person-years, with an IRR significantly higher among women or patients with better education, or shorter duration or on pumps. The IRR was lower in patients with higher BMI or neuropathy or aged more than 50 years.

Conclusions

Fewer than 20 % of T1DM patients are free from hypoglycemia, with one in six having experienced at least one severe episode in the last year. The distribution is uneven, with a tendency of episodes to cluster in some patients. Severe and symptomatic episodes have different correlates and reflect different conditions.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
2.
Zurück zum Zitat Briscoe VJ, Davis SN (2006) Hypoglycemia in type 1 and type 2 diabetes: physiology, pathophysiology, and management. Clin Diabetes 24(3):115–121CrossRef Briscoe VJ, Davis SN (2006) Hypoglycemia in type 1 and type 2 diabetes: physiology, pathophysiology, and management. Clin Diabetes 24(3):115–121CrossRef
3.
Zurück zum Zitat The DCCT Research Group (1991) Epidemiology of severe hypoglycemia in the diabetes control and complications trial. Am J Med 90(4):450–459CrossRef The DCCT Research Group (1991) Epidemiology of severe hypoglycemia in the diabetes control and complications trial. Am J Med 90(4):450–459CrossRef
4.
Zurück zum Zitat The DCCT Research Group (1997) Hypoglycemia in the diabetes control and complications trial. Diabetes 46:271–286CrossRef The DCCT Research Group (1997) Hypoglycemia in the diabetes control and complications trial. Diabetes 46:271–286CrossRef
5.
Zurück zum Zitat Beck RW, Hirsch IB, Laffel L, Tamborlane WV, Bode BW, Buckingham B, Chase P, Clemons R, Fiallo-Scharer R, Fox LA, Gilliam LK, Huang ES, Kollman C, Kowalski AJ, Lawrence JM, Lee J, Mauras N, O’Grady M, Ruedy KJ, Tansey M, Tsalikian E, Weinzimer SA, Wilson DM, Wolpert H, Wysocki T, Xing D (2009) The effect of continuous glucose monitoring in well-controlled type 1 diabetes. Diabetes Care 32(8):1378–1383. doi:10.2337/dc09-0108 CrossRefPubMed Beck RW, Hirsch IB, Laffel L, Tamborlane WV, Bode BW, Buckingham B, Chase P, Clemons R, Fiallo-Scharer R, Fox LA, Gilliam LK, Huang ES, Kollman C, Kowalski AJ, Lawrence JM, Lee J, Mauras N, O’Grady M, Ruedy KJ, Tansey M, Tsalikian E, Weinzimer SA, Wilson DM, Wolpert H, Wysocki T, Xing D (2009) The effect of continuous glucose monitoring in well-controlled type 1 diabetes. Diabetes Care 32(8):1378–1383. doi:10.​2337/​dc09-0108 CrossRefPubMed
6.
Zurück zum Zitat Donnelly LA, Morris AD, Frier BM, Ellis JD, Donnan PT, Durrant R et al (2005) Frequency and predictors of hypoglycemia in type 1 and insulin-treated type 2 diabetes: a population based study. Diabet Med 22(6):749–755CrossRefPubMed Donnelly LA, Morris AD, Frier BM, Ellis JD, Donnan PT, Durrant R et al (2005) Frequency and predictors of hypoglycemia in type 1 and insulin-treated type 2 diabetes: a population based study. Diabet Med 22(6):749–755CrossRefPubMed
7.
Zurück zum Zitat Heller SR, Choudhary P, Davies C, Emery C, Campbell MJ et al (2007) Risk of hypoglycaemia in types 1 and 2 diabetes: effects of treatment modalities and their duration. Diabetologia 50(6):1140–1147CrossRef Heller SR, Choudhary P, Davies C, Emery C, Campbell MJ et al (2007) Risk of hypoglycaemia in types 1 and 2 diabetes: effects of treatment modalities and their duration. Diabetologia 50(6):1140–1147CrossRef
8.
Zurück zum Zitat Pedersen-Bjergaard U, Pramming S, Thorsteinsson B (2003) Recall of severe hypoglycaemia and self-estimated state of awareness in type 1 diabetes. Diabetes Metab Res Rev 19(3):232–240CrossRefPubMed Pedersen-Bjergaard U, Pramming S, Thorsteinsson B (2003) Recall of severe hypoglycaemia and self-estimated state of awareness in type 1 diabetes. Diabetes Metab Res Rev 19(3):232–240CrossRefPubMed
9.
Zurück zum Zitat Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF III, Feldman HI, Kusek JW, Eggers P, Van Lente F, Greene T, Coresh J, CKD-EPI (Chronic Kidney Disease Epidemiology Collaboration) (2009) A New Equation to Estimate Glomerular Filtration Rate. Ann Intern Med 150(9):604–612PubMedCentralCrossRefPubMed Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF III, Feldman HI, Kusek JW, Eggers P, Van Lente F, Greene T, Coresh J, CKD-EPI (Chronic Kidney Disease Epidemiology Collaboration) (2009) A New Equation to Estimate Glomerular Filtration Rate. Ann Intern Med 150(9):604–612PubMedCentralCrossRefPubMed
10.
Zurück zum Zitat Giorda CB, Ozzello A, Gentile S, Corsi A, Iannarelli R, Baccetti F, Lucisano G, Nicolucci A, Rossi MC (2014) On behalf the HYPOS-1 study group. incidence and correlates of hypoglycemia in type 2 diabetes. The hypos-1 study. J Diabetes Metab 5:3. doi:10.4172/2155-6156.1000344 Giorda CB, Ozzello A, Gentile S, Corsi A, Iannarelli R, Baccetti F, Lucisano G, Nicolucci A, Rossi MC (2014) On behalf the HYPOS-1 study group. incidence and correlates of hypoglycemia in type 2 diabetes. The hypos-1 study. J Diabetes Metab 5:3. doi:10.​4172/​2155-6156.​1000344
11.
Zurück zum Zitat ter Braak EW, Appelman AM, van de Laak M, Stolk RP, van Haeften TW, Erkelens DW (2000) Clinical characteristics of type 1 diabetic patients with and without severe hypoglycemia. Diabetes Care 23(10):1467–1471CrossRefPubMed ter Braak EW, Appelman AM, van de Laak M, Stolk RP, van Haeften TW, Erkelens DW (2000) Clinical characteristics of type 1 diabetic patients with and without severe hypoglycemia. Diabetes Care 23(10):1467–1471CrossRefPubMed
12.
Zurück zum Zitat The DCCT Research Group (1993) The effect of intensive treatment of diabetes on the development and progression of long term complication in insulin-dependent diabetes mellitus. N Engl J Med 329:977–986CrossRef The DCCT Research Group (1993) The effect of intensive treatment of diabetes on the development and progression of long term complication in insulin-dependent diabetes mellitus. N Engl J Med 329:977–986CrossRef
13.
Zurück zum Zitat Hepburn DA, MacLeod KM, Pell AC, Scougal IJ, Frier BM (1993) Frequency and symptoms of hypoglycaemia experienced by patients with type 2 diabetes treated with insulin. Diabet Med 10:231–237CrossRefPubMed Hepburn DA, MacLeod KM, Pell AC, Scougal IJ, Frier BM (1993) Frequency and symptoms of hypoglycaemia experienced by patients with type 2 diabetes treated with insulin. Diabet Med 10:231–237CrossRefPubMed
14.
Zurück zum Zitat Pedersen-Bjergaard U, Kristensen PL, Beck-Nielsen H, Nørgaard K, Perrild H, Christiansen JS, Jensen T, Hougaard P, Parving HH, Thorsteinsson B, Tarnow L (2014) Effect of insulin analogues on risk of severe hypoglycaemia in patients with type 1 diabetes prone to recurrent severe hypoglycaemia (HypoAna trial): a prospective, randomised, open-label, blinded-endpoint crossover trial. Lancet Diabetes Endocrinol 2(7):553–561CrossRefPubMed Pedersen-Bjergaard U, Kristensen PL, Beck-Nielsen H, Nørgaard K, Perrild H, Christiansen JS, Jensen T, Hougaard P, Parving HH, Thorsteinsson B, Tarnow L (2014) Effect of insulin analogues on risk of severe hypoglycaemia in patients with type 1 diabetes prone to recurrent severe hypoglycaemia (HypoAna trial): a prospective, randomised, open-label, blinded-endpoint crossover trial. Lancet Diabetes Endocrinol 2(7):553–561CrossRefPubMed
15.
Zurück zum Zitat Amiel SA, Maran A, Powrie JK, Umpleby AM, MacDonald IA (1993) Gender differences in counterregulation to hypoglycemia. Diabetologia 36:460–464CrossRefPubMed Amiel SA, Maran A, Powrie JK, Umpleby AM, MacDonald IA (1993) Gender differences in counterregulation to hypoglycemia. Diabetologia 36:460–464CrossRefPubMed
16.
Zurück zum Zitat Davis SN, Goldstein RE, Price L, Jacobs J, Cherringon AD (1993) The effects of insulin on the counterregulatory response to equivalent hypoglycaemia in patients with insulin-dependent diabetes mellitus. J Clin Endocrinol Metab 77:1300–1307PubMed Davis SN, Goldstein RE, Price L, Jacobs J, Cherringon AD (1993) The effects of insulin on the counterregulatory response to equivalent hypoglycaemia in patients with insulin-dependent diabetes mellitus. J Clin Endocrinol Metab 77:1300–1307PubMed
17.
Zurück zum Zitat Diamond MP, Jones T, Caprio S, Hallarman L, Diamond MC, Addabbo M, Tamborlane WV, Sherwin RS (1993) Gender influences counterregulatory hormone responses to hypoglycemia. Metabolism 42:1568–1572CrossRefPubMed Diamond MP, Jones T, Caprio S, Hallarman L, Diamond MC, Addabbo M, Tamborlane WV, Sherwin RS (1993) Gender influences counterregulatory hormone responses to hypoglycemia. Metabolism 42:1568–1572CrossRefPubMed
18.
Zurück zum Zitat Davis SN, Fowler S, Costa F (2000) Hypoglycemic counterregulatory responses differ between men and women with type 1 diabetes. Diabetes 49:65–72CrossRefPubMed Davis SN, Fowler S, Costa F (2000) Hypoglycemic counterregulatory responses differ between men and women with type 1 diabetes. Diabetes 49:65–72CrossRefPubMed
19.
Zurück zum Zitat Sandoval DA, Ertl AC, Richardson MA, Tate DB, Davis SN (2003) Estrogen blunts neuroendocrine and metabolic responses to hypoglycemia. Diabetes 52:1749–1755CrossRefPubMed Sandoval DA, Ertl AC, Richardson MA, Tate DB, Davis SN (2003) Estrogen blunts neuroendocrine and metabolic responses to hypoglycemia. Diabetes 52:1749–1755CrossRefPubMed
20.
Zurück zum Zitat Cherubini V, Pintaudi B, Rossi MC, Lucisano G, Pellegrini F, Chiumello G, Frongia AP, Monciotti C, Patera IP, Toni S, Zucchini S (2014) Nicolucci A; SHIP-D Study Group. Severe hypoglycemia and ketoacidosis over one year in Italian pediatric population with type 1 diabetes mellitus: a multicenter retrospective observational study. Nutr Metab Cardiovasc Dis 24(5):538–546CrossRefPubMed Cherubini V, Pintaudi B, Rossi MC, Lucisano G, Pellegrini F, Chiumello G, Frongia AP, Monciotti C, Patera IP, Toni S, Zucchini S (2014) Nicolucci A; SHIP-D Study Group. Severe hypoglycemia and ketoacidosis over one year in Italian pediatric population with type 1 diabetes mellitus: a multicenter retrospective observational study. Nutr Metab Cardiovasc Dis 24(5):538–546CrossRefPubMed
21.
Zurück zum Zitat McAulay V, Deary IJ, Frier BM (2001) Symptoms of hypoglycaemia in people with diabetes. Diabet Med 18(9):690–705CrossRefPubMed McAulay V, Deary IJ, Frier BM (2001) Symptoms of hypoglycaemia in people with diabetes. Diabet Med 18(9):690–705CrossRefPubMed
22.
Zurück zum Zitat Kilpatrick ES, Rigby AS, Goode K, Atkin SL (2007) Relating mean blood glucose and glucose variability to the risk of multiple episodes of hypoglycemia in type 1 diabetes. Diabetologia 50:2553–2561CrossRefPubMed Kilpatrick ES, Rigby AS, Goode K, Atkin SL (2007) Relating mean blood glucose and glucose variability to the risk of multiple episodes of hypoglycemia in type 1 diabetes. Diabetologia 50:2553–2561CrossRefPubMed
23.
Zurück zum Zitat Sartore G, Chilelli NC, Burlina S, Di Stefano P, Piarulli F, Fedele D, Mosca A, Lapolla A (2012) The importance of HbA1c and glucose variability in patients with type 1 and type 2 diabetes: outcome of continuous glucose monitoring (CGM). Acta Diabetol 49(Suppl 1):S153–S160CrossRefPubMed Sartore G, Chilelli NC, Burlina S, Di Stefano P, Piarulli F, Fedele D, Mosca A, Lapolla A (2012) The importance of HbA1c and glucose variability in patients with type 1 and type 2 diabetes: outcome of continuous glucose monitoring (CGM). Acta Diabetol 49(Suppl 1):S153–S160CrossRefPubMed
24.
Zurück zum Zitat Bergenstal RM, Klonoff DC, Garg SK, Bode BW, Meredith M, Slover RH, Ahmann AJ, Welsh JB, Lee SW (2013) Kaufman FR; ASPIRE In-Home Study Group. Threshold-based insulin-pump interruption for reduction of hypoglycemia. N Engl J Med 369(3):224–232CrossRefPubMed Bergenstal RM, Klonoff DC, Garg SK, Bode BW, Meredith M, Slover RH, Ahmann AJ, Welsh JB, Lee SW (2013) Kaufman FR; ASPIRE In-Home Study Group. Threshold-based insulin-pump interruption for reduction of hypoglycemia. N Engl J Med 369(3):224–232CrossRefPubMed
25.
Zurück zum Zitat Seaquist ER, Anderson J, Childs B, Cryer P, Dagogo-Jack S et al (2013) Hypoglycemia and diabetes: a report of a workgroup of the American Diabetes Association and the Endocrine Society. Diabetes Care 36(5):1384–1395PubMedCentralCrossRefPubMed Seaquist ER, Anderson J, Childs B, Cryer P, Dagogo-Jack S et al (2013) Hypoglycemia and diabetes: a report of a workgroup of the American Diabetes Association and the Endocrine Society. Diabetes Care 36(5):1384–1395PubMedCentralCrossRefPubMed
Metadaten
Titel
Incidence and risk factors for severe and symptomatic hypoglycemia in type 1 diabetes. Results of the HYPOS-1 study
verfasst von
Carlo B. Giorda
Alessandro Ozzello
Sandro Gentile
Alberto Aglialoro
Anna Chiambretti
Fabio Baccetti
Francesco M. Gentile
Giuseppe Lucisano
Antonio Nicolucci
Maria Chiara Rossi
HYPOS-1 Study Group of AMD
Publikationsdatum
01.10.2015
Verlag
Springer Milan
Erschienen in
Acta Diabetologica / Ausgabe 5/2015
Print ISSN: 0940-5429
Elektronische ISSN: 1432-5233
DOI
https://doi.org/10.1007/s00592-015-0713-4

Weitere Artikel der Ausgabe 5/2015

Acta Diabetologica 5/2015 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.